FilingReader Intelligence

Genor Biopharma delays merger circular to October

July 25, 2025 at 09:29 AM UTC•By FilingReader AI

Genor Biopharma has extended the despatch of its circular for a proposed reverse takeover to on or before 31 October 2025.

The company submitted its new listing application to the stock exchange on 15 April 2025. The merger closing and listing remain subject to regulatory approvals.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLANJuly 25, 2025 at 09:20 AM UTC

Genor Biopharma Holdings

HKEX:6998•Hong Kong Exchange

RSS feed for Genor Biopharma Holdings

News Alerts

Get instant email alerts when Genor Biopharma Holdings publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →